Baxter International Inc. have announced the appointment of Andrew Hider as its new Chief Executive Officer. Andrew, who brings over two decades of leadership in the healthcare and consumer sectors, will officially assume the CEO role later this month. He succeeds current CEO, who has guided Baxter through a period of transformation focused on sustainable growth and patient‐centered solutions.
Proven Global Execution and Operational Expertise
Andrew joins Baxter from his previous role as CEO of ATS Corporation , where he oversaw global operations and delivered consistent, high‑quality outcomes. His substantial experience in managing large teams and driving operational excellence positions him to strengthen Baxter’s global supply chain resilience, accelerate product innovation, and enhance patient and customer experiences worldwide.
Commitment to Patient‑Centered Innovation
A key pillar of Baxter’s mission is delivering safe, effective therapies to patients across the globe. Andrew Hider shares that commitment wholeheartedly. Under his leadership, the company intends to invest further in advanced therapies, digital health platforms, and sustainable manufacturing processes. These strategic initiatives aim to reinforce Baxter’s leadership in renal care, infusion systems, and hospital products.
Vision for Sustainable and Responsible Growth
Reflecting on his appointment, Andrew Hider stated: “I’m honoured to join Baxter at this pivotal time. I look forward to working with our talented team to accelerate innovation, deepen our impact on patient care, and drive long‑term value for all stakeholders.” His vision encompasses both financial strength and social responsibility, emphasising environmental sustainability and access to care.
Focus on Talent and Culture
Recognising that people are Baxter’s greatest asset, Andrew Hider plans to foster a culture of collaboration, accountability, and continuous learning. By empowering employees and investing in leadership development, he aims to support innovation and agility across all business units.
Andrew Hider’s appointment marks an exciting new chapter for Baxter. With his proven track record in operational leadership, commitment to innovation, and patient‑centric vision, Baxter is well positioned to drive sustainable growth, enhance patient outcomes, and deliver long‑term value to customers, employees, and shareholders alike.